Atea Pharmaceuticals had the highest capex growth among pharma and biotech companies worldwide during the 2022 period, with a growth rate of over 48,000 percent. Capital expenditures are defined as funds used by a company to acquire or upgrade physical assets, such as property, industrial buildings, or equipment.
U.S. pharmaceutical and biotech industry
Several of the pharmaceutical and biotech companies with high capex growth rates are based in the United States, for example, Cara Therapeutics, Prokidney, and Kymera Therapeutics. In 2023, the country accounted for over 44 percent of the global pharmaceutical market. China, which has a much larger population than the United States, had a roughly seven percent market share. In the same year, the United States had a nominal spending on medicine of over 700 billion U.S. dollars. This was more than double the amount spent back in 2013.
In 2023, the largest American pharmaceutical company based on revenue was Johnson & Johnson. The multinational biopharmaceutical company is headquartered in New Jersey and annually generates more than 85 billion U.S. dollars’ worth of annual revenue, as of 2024.
World's top 50 pharmaceutical and biotechnology companies based on capital expenditure growth in 2023
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
European Commission, & Joint Research Centre. (December 15, 2024). World's top 50 pharmaceutical and biotechnology companies based on capital expenditure growth in 2023 [Graph]. In Statista. Retrieved December 23, 2024, from https://www.statista.com/statistics/524646/top-pharma-and-biotech-companies-by-capex-growth-in-3-years/
European Commission, und Joint Research Centre. "World's top 50 pharmaceutical and biotechnology companies based on capital expenditure growth in 2023." Chart. December 15, 2024. Statista. Accessed December 23, 2024. https://www.statista.com/statistics/524646/top-pharma-and-biotech-companies-by-capex-growth-in-3-years/
European Commission, Joint Research Centre. (2024). World's top 50 pharmaceutical and biotechnology companies based on capital expenditure growth in 2023. Statista. Statista Inc.. Accessed: December 23, 2024. https://www.statista.com/statistics/524646/top-pharma-and-biotech-companies-by-capex-growth-in-3-years/
European Commission, and Joint Research Centre. "World's Top 50 Pharmaceutical and Biotechnology Companies Based on Capital Expenditure Growth in 2023." Statista, Statista Inc., 15 Dec 2024, https://www.statista.com/statistics/524646/top-pharma-and-biotech-companies-by-capex-growth-in-3-years/
European Commission & Joint Research Centre, World's top 50 pharmaceutical and biotechnology companies based on capital expenditure growth in 2023 Statista, https://www.statista.com/statistics/524646/top-pharma-and-biotech-companies-by-capex-growth-in-3-years/ (last visited December 23, 2024)
World's top 50 pharmaceutical and biotechnology companies based on capital expenditure growth in 2023 [Graph], European Commission, & Joint Research Centre, December 15, 2024. [Online]. Available: https://www.statista.com/statistics/524646/top-pharma-and-biotech-companies-by-capex-growth-in-3-years/
